Motif Bio PLC | |
Stock Exchange | Other OTC |
EPS |
$0.07 |
Market Cap |
$10.27 M |
Shares Outstanding |
296.53 M |
Public Float |
276.45 M |
Motif Bio PLC | |
Stock Exchange | London Stock Exchange |
EPS |
GBP0.05 |
Market Cap |
GBP7.88 M |
Shares Outstanding |
342.49 M |
Public Float |
- |
Address |
5 Independence Way Princeton New Jersey 08540 United States |
Employees | - |
Website | https://www.motifbio.com/ |
Updated | 07/08/2019 |
Motif Bio Plc is a clinical stage biopharmaceutical company which develops novel antibiotics designed to be effective against serious and life-threatening infections caused by multi-drug resistant bacteria. It pipeline of antibiotics includes iclaprim, and MTF-001, a preclinical program to design a dihydrofolate reductase inhibitor (DHFRi). The company was founded on November 20, 2014 and is headquartered in New York, NY. |